Sign in
JAGX Stock Price, Chart, Stats & News
Jaguar Health, Inc.
Save
Jaguar Health, Inc. (JAGX) does not currently pay a dividend.
3.06M
Market cap
–
Current P/E
200.00x
Forward P/E
JAGX chart
Fundamentals
Gross margin | 77.17% |
Operating margin | -278.52% |
Pretax margin | -348.22% |
Net margin | -341.90% |
Effective tax rate | – |
ROA | -81.45% |
ROE | -710.57% |
D/E | 5.67x |
Interest coverage ratio | -5470.50x |
JAGX valuation
P/E | – |
P/S | 0.06x |
P/B | 0.09x |
P/CF | -0.02x |
P/FCF | -0.03x |
P/OCF | -0.02x |
PEG | -0.00x |
EV multiple | 0.67x |
About
Jaguar Health, Inc., a commercial-stage pharmaceutical firm, specializes in developing prescription therapies for both human and animal patients afflicted by gastrointestinal ailments, particularly chronic and severe diarrhea. Its operations are structured into two distinct divisions: Human Health and Animal Health. Presently, the company markets Mytesi, an approved medication providing symptomatic relief for noninfectious diarrhea experienced by adults with HIV/AIDS undergoing antiretroviral therapy.
Similar securities
Based on sector and market capitalization
Report issue